ENTITY

Grifols (GRF SQ)

-1
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
17 Dec 2024 21:10

Liquid Universe of European Ordinary and Preferred Shares: December‘24 Report

Since mid-November, share-price spreads have generally widened across European liquid universe of ordinary and preferred shares with few changes in...

Share
15 Dec 2024 06:45

Last Week in Event SPACE: NEC Network, SingPost, Seven & I, CPMC, Exedy

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
533 Views
Share
bullishGrifols SA
13 Dec 2024 07:17

Grifols: Activism and Debt Refinancing

​Grifols strengthens liquidity through debt refinancing, faces activist shareholder pressure for governance reforms, and presents a valuation...

Share
01 Dec 2024 06:30

Last Week in Event SPACE: Keisei Electric Railway, Vitasoy, NEC Network, ESR Group

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
599 Views
Share
bullishGrifols SA
28 Nov 2024 06:52

Brookfield's Bid for Grifols Collapses

​Brookfield withdraws €6.45 billion takeover bid for Grifols due to valuation disagreements, shareholder resistance, and financing challenges.

Share
x